Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Alliances symbols : GSK save search
Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production Technology
Published: 2024-01-24 (Crawled : 13:30) - biospace.com/
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.48%
H: 0.66%
C: -1.11%
collaboration dna technology agreement
Elsie Biotechnologies Announces Collaboration with GSK to Accelerate Oligonucleotide Discovery Technologies
Published: 2023-07-10 (Crawled : 12:00) - biospace.com/
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -0.09%
H: 0.59%
C: 0.21%
collaboration
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA.2 Subvariant
Published: 2022-03-25 (Crawled : 21:00) - biospace.com/
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 4.57%
H: 0.0%
C: -3.26%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: -0.7%
H: 1.94%
C: -1.47%
VIR | $8.13 0.37% 0.37% 770K
|
Health Technology
|
| O: -1.07%
H: 0.8%
C: -12.62%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
drug food authorization emergency use authorization
908 Devices Announces GSK Purchases Fifth REBEL Cell Culture Media Analyzer
Published: 2022-01-07 (Crawled : 13:00) - biospace.com/
MASS | $5.55 -0.72% -0.72% 270K
|
|
| O: -10.29%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
ces device cel media
Lilly, Vir Biotechnology and GSK Announce Positive Topline Data from the Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab with VIR-7831 in Low-Risk Adults with COVID-19
Published: 2021-03-29 (Crawled : 14:00) - biospace.com/
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -0.82%
H: 1.18%
C: 0.88%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.35%
H: 1.63%
C: 0.91%
VIR | $8.13 0.37% 0.37% 770K
|
Health Technology
|
| O: -1.46%
H: 1.02%
C: -4.73%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.56%
H: 0.83%
C: 0.57%
covid phase 2 risk positive topline biotech technology iot trial
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.